Firstpost | World Cancer Day: Debate on affordable drugs must focus on life or death for ... Firstpost In contrast, the compulsory licence for Nexavar (sorafenib tosylate, a drug used in the treatment of kidney and liver cancers), was India's first, granted on the grounds that Bayer had failed to make the drug affordable and available in the required ... |
